By Katabella Roberts Contributing Writer The Centers for Disease Control and Prevention has changed its recommendations ...

In preparation for the upcoming respiratory virus season, the Centers for Disease Control and Prevention (CDC) recently ...

"This real-world study ... indicated that nirsevimab prophylaxis was effective against RSV-associated bronchiolitis leading ...

About 20% of New Yorkers ages 60 and older took the RSV shot. Now CDC updated recommendations. What you should know ...

The updated recommendation is designed to make decision-making about the RSV vaccine easier for health care workers and the ...

Expectant mothers who get vaccinated to protect their newborns against respiratory syncytial virus (RSV) are not putting ...

The new guidelines only apply to adults who did not get an RSV vaccine last year, the CDC noted. HealthDay News — In new vaccination guidance issued Wednesday, US health officials now recommend that ...

The new CDC report examines the first year of safety ... Unlike the flu or COVID-19, there is no antiviral treatment available for RSV. Rather, treatment involves maintaining a person's vitals ...

The CDC has revised its criteria for who should get an RSV vaccine. The agency is strongly urging vaccination for people who are 75 and older. People who are 60 and older with chronic health ...

Nirsevimab therapy also effective against RSV-linked bronchiolitis resulting in critical care, ventilatory support for ...